Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

AGM Statement

23 Jul 2025 07:00

RNS Number : 1129S
Symphony Environmental Tech. PLC
23 July 2025
 

 

23 July 2025

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or the "Group")

AGM Statement

 

Symphony Environmental Technologies Plc (AIM:SYM) global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable" announces that its Chairman will make the following statement at today's Annual General Meeting.

"I am very pleased to report that momentum within the business continues, and our prospects look strong, especially in the short to medium term. We are seeing a high level of sales prospects nearing completion and expected to close in the second half of the year or shortly after.

A major highlight this year has been the long-awaited regulatory breakthrough in the EU. As announced on 8 July 2025, the Environmental Protection Agency ("EPA") of Ireland (an EU Member-State) confirmed that Symphony's d2w biodegradable plastic technology is compliant with EU Directive (EU) 2019/904 (the "Directive"). Other European markets can be expected to follow.

This confirmation of compliance is the result of a thorough scientific review by the EPA of Ireland of a large file of independent scientific reports which confirm that products with d2w technology fully biodegrade without leaving persistent microplastics or toxic residues: a critical distinction from oxo-degradable plastics - which are restricted under the Directive.

The EPA of Ireland has also reviewed the Commission Notice (2021/C 216/01) of 7 June 2021, which provides guidelines on the implementation of Directive (EU) 2019/904. They said, "Based on the evidence submitted, we are satisfied that d2w products are not subject to the restrictions outlined in the Directive or its accompanying guidelines."

It is important to note that the scientific evidence submitted to the EPA related to d2w only, and their approval therefore relates only to d2w and to no other biodegradable plastic.

This development is not only an official validation of our technology but also a strategic enabler for growth of d2w across Europe and in other global markets which align with the EU's environmental strategies.

Indeed, it marks a significant turning point in our commercial trajectory and strengthens our leadership in the market for sustainable plastic solutions that have little or no on-cost and are non-disruptive to supply-chains.

Our d2p range of products, as reported in our preliminary results on 12 June continues to progress in the following main areas. Antimicrobial for bread and other food applications, flame retardants, fragrance scents for use in refrigerators, and anti-insect applications for water pipe and some food packing protection. 

Our balance sheet was strengthened by the equity capital-raise announced on 10 June of £2.25 million at 20 pence per share.

Revenues for the first half of 2025 were approximately £2.9 million (H1 2024: £3.4 million). While Q2 2025 was particularly light, this was due to order timing in key markets and is not indicative of underlying trading conditions. We expect a stronger performance in the second half as expected orders are received, and our opportunities commercialise further.

Our gross margins have continued to strengthen and are expected to be approximately 5 percentage points higher than H1-2024. Costs have continued to reduce.

Symphony remains well positioned globally, operating a capital-light, operationally- geared business model. We continue to work closely with a global network of experienced distributors and manufacturing partners in key territories."

 

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

Dominic King (Sales)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. Instead they will safely biodegrade, leaving no microplastics or toxicity. If they get collected during their useful life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEAFLEEISEIW
Date   Source Headline
29th May 201812:51 pmRNSDirector/PDMR Shareholding
21st May 20181:01 pmRNSExercise of Warrants and Director Dealing
15th May 20184:40 pmRNSSecond Price Monitoring Extn
15th May 20184:35 pmRNSPrice Monitoring Extension
15th May 201812:02 pmRNSResult of AGM
15th May 20187:01 amRNSAGM Statement
15th May 20187:00 amRNSTrading and Operations Update
3rd May 20187:00 amRNSNew Product Launches
1st May 20187:00 amRNSCollaboration Agreement and Strategic Investment
20th Apr 20187:00 amRNSSymphony Director on Sky News
19th Apr 20187:00 amRNSPosting of Accounts and Notice of AGM
18th Apr 20187:00 amRNSResults of YouGov survey
10th Apr 20187:00 amRNSOxo-biodegradable plastic legislation
9th Apr 20188:10 amRNSRemarks Delivered at 2018 ECOSOC Partnership Forum
6th Apr 20187:00 amRNSDirectorate Change
22nd Mar 201810:35 amRNSDirector Shareholding
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20183:57 pmRNSExercise of Options & Issue of New Ordinary Shares
2nd Mar 20187:00 amRNSExercise of Options
30th Jan 20187:00 amRNSIntroduction to d2w on the BBC World Service
12th Jan 201810:14 amRNSInterview on Sky News
8th Jan 20182:43 pmRNSDirector/PDMR Shareholding
4th Jan 20184:15 pmRNSExercise of Options
4th Jan 20184:09 pmRNSExercise of Options & Issue of New Ordinary
4th Jan 20187:00 amRNSTrading Update
15th Dec 20177:00 amRNSCourt Approval of Capital Reduction
30th Nov 20177:00 amRNSCapital Reduction Effective Date
8th Nov 201712:26 pmRNSResult of EGM
7th Nov 20171:57 pmRNSNotification of Major Holdings
27th Oct 20177:00 amRNSTrading Update
19th Oct 20177:00 amRNSProposed Capital Reduction & Notice of EGM
29th Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSInterim Results
11th Jul 20173:49 pmRNSHolding(s) in Company
31st May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20172:34 pmRNSDirector/PDMR Shareholding
12th May 201710:54 amRNSResult of AGM
12th May 20177:00 amRNSAGM Statement
9th May 20174:34 pmRNSExercise of Options
9th May 201710:47 amRNSExercise of Options
4th May 201711:25 amRNSDirector/PDMR Shareholding
3rd May 201711:29 amRNSExercise of Options and Director Dealing
25th Apr 20173:19 pmRNSDirector/PDMR Shareholding
25th Apr 20178:54 amRNSDirector/PDMR Shareholding
20th Apr 201712:43 pmRNSDirector/PDMR Shareholding
19th Apr 201712:31 pmRNSExercise of Options
19th Apr 20177:00 amRNSSaudi Arabia Legislation Enforcement
6th Apr 20177:00 amRNSAdmission of Securities to Trading on AIM
28th Mar 20178:27 amRNSExercise of Options and Issue of Equity
27th Mar 20178:13 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.